Xtandi (INN enzalutamide) Timeline

Revised February 14, 2022 Early 2000 UCLA claims work that led to the development of enzalutamide began at UCLA in early 2000. 2005 May 13, 2005.  Priority date for the three patents in the Xtandi Orange Book. Patents 7709517, 8183274… Continue Reading

Israel issues compulsory license to allow the government to import generic versions of Kaletra

(More on COVID-19 here: https://www.keionline.org/coronavirus) On Wednesday, 18 March 2020 (22nd of Adar, 5780), Israel’s Minister of Health, MP Rabbi Yaacov Litzman, issued a Permit to the State to Exploit an Invention Pursuant to Chapter Six, Article Three of the… Continue Reading